Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy.
Mezeiova E, Korabecny J, Sepsova V, Hrabinova M, Jost P, Muckova L, Kucera T, Dolezal R, Misik J, Spilovska K, Pham NL, Pokrievkova L, Roh J, Jun D, Soukup O, Kaping D, Kuca K.
Mezeiova E, et al. Among authors: korabecny j.
Molecules. 2017 Jul 28;22(8):1265. doi: 10.3390/molecules22081265.
Molecules. 2017.
PMID: 28788095
Free PMC article.